SCHEMBL23905727

SCHEMBL23905727

C/N=C\[C@@]1(CF)COc2c1cc(C(O)(CNC(=O)c1cc(OC)c3ncc(I)cc3c1)C(F)(F)F)nc2-c1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905315 0.83 GABRA5 (0.34) GABRA5
SCHEMBL23905865 0.83 GABRA5 (0.34) GABRA5
SCHEMBL23904693 0.83 GABRA5 (0.34) GABRA5
SCHEMBL23905870 0.82 GABRA5 (0.34) GABRA5
SCHEMBL23905286 0.82 GABRA5 (0.33) GABRA5
SCHEMBL23905269 0.82 CFTR (0.34) GABRA5
SCHEMBL23905868 0.82 GABRA5 (0.34) GABRA5
SCHEMBL23905728 0.82 GABRA5 (0.34) GABRA5
SCHEMBL24988033 0.82 GABRA5 (0.35) GABRA5
SCHEMBL23905718 0.81 CFTR (0.32) GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed